|
TRIM5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.444600E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.018600E-01 |
| Normal-vs-Stage2 |
8.960500E-02 |
| Normal-vs-Stage3 |
3.578600E-04 |
| Normal-vs-Stage4 |
1.003420E-04 |
| Stage1-vs-Stage2 |
3.882200E-01 |
| Stage1-vs-Stage3 |
1.082940E-03 |
| Stage1-vs-Stage4 |
6.622000E-04 |
| Stage2-vs-Stage3 |
1.393590E-01 |
| Stage2-vs-Stage4 |
4.363700E-02 |
| Stage3-vs-Stage4 |
3.430000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.352190E-02 |
| Normal-vs-AfricanAmerican |
4.007800E-01 |
| Normal-vs-Asian |
6.824200E-01 |
| Caucasian-vs-AfricanAmerican |
5.134600E-01 |
| Caucasian-vs-Asian |
7.437600E-02 |
| AfricanAmerican-vs-Asian |
5.963800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.399700E-02 |
| Normal-vs-Female |
1.075880E-02 |
| Male-vs-Female |
9.079400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.198200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.156260E-02 |
| Normal-vs-Age(61-80Yrs) |
1.590110E-04 |
| Normal-vs-Age(81-100Yrs) |
3.564200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.618400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.367260E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.980200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.536100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.396400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.777800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.08380000005426E-06 |
| Classical-VS-Follicular |
3.296400E-01 |
| Classical-VS-Other |
8.663200E-01 |
| Classical-VS-Normal |
1.073190E-01 |
| Tall-VS-Follicular |
6.298800E-03 |
| Tall-VS-Other |
2.152400E-02 |
| Tall-VS-Normal |
1.51550000004885E-06 |
| Follicular-VS-Other |
6.601400E-01 |
| Follicular-VS-Normal |
3.274000E-02 |
| Other-VS-Normal |
5.917600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.368200E-02 |
| Normal-vs-N1 |
2.170300E-02 |
| N0-vs-N1 |
3.639000E-01 |
|
|
